엔젠바이오

354200KOSDAQ그외 기타 전문, 과학 및 기술 서비스업

51.8 / 100

Reference Date: 2026-06-10

Financial Score18.5 / 40

News Sentiment21.3 / 25

Momentum2.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 16.4% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

EnzenBio is a biotech company specializing in in vitro diagnostic medical devices and services using genomic analysis, liquid biopsy, and precision diagnostics. It leverages next-generation sequencing (NGS) and bioinformatics algorithms to detect mutations in cancer and genetic diseases, offering personalized treatment solutions.

Number of Employees

56people

Average Salary

61.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 48.804.0Point

PBR

1.13Industry Average 1.434.0Point

In line with industry avg

ROE

-33.54Industry Average 0.940.0Point

Well below industry avg

Debt Ratio

7.51Industry Average 12.515.0Point

Lower than industry avg (good)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲152.0% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲14.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -59.2% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Positive
엔젠바이오, 1분기 매출 전년 대비 36% 증가…“진단사업 성장세”
엔젠바이오의 1분기 매출이 전년 대비 36% 증가하며 진단사업 부문의 성장이 확인되었다.
Positive
"AI로 초정밀 진단에 실탄 확보까지"...엔젠바이오, 실적 반등 승부...
엔젠바이오가 LG AI 연구원과의 협력으로 자금 확보를 통해 실적 개선을 목표로 하고 있어 긍정적 전망.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 949Won52-week high 2,63552-week low 949

1-month return0.0Point

1m -16.39% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0

Neutral임시주주총회결과2026-06-09
Neutral정정신고서제출요구( 2026.05.19. 제출 증권신고서(지분증권) )2026-06-02
Neutral의결권대리행사권유참고서류2026-05-22
Neutral주주총회소집공고2026-05-22
Neutral증권신고서(지분증권)2026-05-19